kff glp-1 Health News | Lots of research suggests that drugs must be used indefinitely to maintain weight loss and related health benefits. But with list KFF Health Tracking Poll: Prescription

One of them is MEDVi GLP-1 receptor agonists such as semaglutide and tirzepatide, which has gained attention because of its ability to control the appetite and decrease weight under the supervision of medical professionals

Contact us today to schedule your first in-home visit and experience the difference of personalized, mobile healthcare in Franklin.

Designed to complement your GLP-1 journey

SPREAD PROTEIN ACROSS THE DAY Hitting your daily protein target is only half of the equation

Clean the rubber stopper with an alcohol swab

The findings, which were presented over the weekend at ENDO 2026, the Endocrine Society's annual meeting, were based on an analysis of health records from more than 42,000 adults who were already taking at least two types of blood pressure medications when they began treatment with GLP-1 drugs such as semaglutide, tirzepatide or liraglutide